Picture of ForgeRock logo

FORG — ForgeRock News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid Cap

U.S. RESEARCH ROUNDUP-Adamas Pharmaceuticals, Carvana, Parker-Hannifin

Oct 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Adamas Pharmaceuticals, Carvana and Parker-Hannifin
on Tuesday. 
    
  HIGHLIGHTS        
     * Adamas Pharmaceuticals Inc  ADMS.O : Piper Sandler cuts to neutral from overweight
     * Carvana Co  CVNA.N : JP Morgan raises target price to $345 from $325
     * Flexion Therapeutics Inc  FLXN.O : Credit Suisse cuts to neutral from outperform
     * Parker-Hannifin Corp  PH.N : Melius Research raises to buy from hold
     * Ulta Beauty Inc  ULTA.O : JP Morgan raises target price to $430 from $425
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.    
     * Adamas Pharmaceuticals Inc  ADMS.O : Piper Sandler cuts to neutral from overweight
     * Adamas Pharmaceuticals Inc  ADMS.O : Piper Sandler raises target price to $8 from $7
     * Adamas Pharmaceuticals Inc  ADMS.O : SVB Leerink cuts to market perform from outperform
     * Adamas Pharmaceuticals Inc  ADMS.O : SVB Leerink raises target price to $8 from $6
     * Aptiv Plc  APTV.N : CFRA cuts target price by $10 to $125
     * Aptiv Plc  APTV.N : Daiwa Capital Markets raises target price to $180 from $165
     * Aptiv Plc  APTV.N : Jefferies raises target price to $185 from $184
     * Aptiv Plc  APTV.N : Piper Sandler cuts target price to $177 from $182
     * Aspen Technology Inc  AZPN.O : Baird raises target price to $170 from $145
     * Athenex Inc  ATNX.O : RBC cuts target price to $5 from $8
     * Avangrid Inc  AGR.N : JP Morgan cuts target price to $47 from $50
     * Baidu Inc  BIDU.O : CFRA cuts target price by $10 to $110
     * Carlyle Group Inc  CG.O : JP Morgan raises target price to $60 from $59
     * Carvana Co  CVNA.N : JP Morgan raises target price to $345 from $325
     * ChampionX Corp  CHX.O : Piper Sandler raises target price to $23 from $22.5
     * Cinemark Holdings Inc  CNK.N : JP Morgan raises target price to $23 from $20
     * Coca-Cola Co  KO.N : JP Morgan raises target price to $60 from $59
     * Dutch Bros Inc  BROS.N : Baird initiates coverage with outperform rating and $56 PT
     * Evolent Health Inc  EVH.N : Canaccord Genuity raises target price to $37 from $27
     * First Solar Inc  FSLR.O : Susquehanna raises target price to $123 from $120
     * Flexion Therapeutics Inc  FLXN.O : Credit Suisse cuts to neutral from outperform
     * Flexion Therapeutics Inc  FLXN.O : Credit Suisse cuts target price to $10 from $14
     * Forgerock Inc  FORG.N : Cowen and Company initiates at outperform with PT $45
     * Franklin Resources Inc  BEN.N : JP Morgan cuts target price to $32 from $35
     * Halliburton Co  HAL.N : Piper Sandler raises target price to $26 from $25.5
     * Invesco Ltd  IVZ.N : JP Morgan cuts target price to $30 from $32
     * Isos Acquisition Corp  ISOS.N : MKM Partners initiates coverage with buy rating; $13 PT
     * Koninklijke Ahold Delhaize NV  AD.AS : Goldman Sachs cuts to neutral from buy
     * Marathon Oil Corp  MRO.N : Wells Fargo raises target price to $19 from $18
     * Netflix Inc  NFLX.O : Jefferies raises target price to $737 from $620
     * Nov Inc  NOV.N : Piper Sandler raises target price to $13.7 from $13
     * ON Holding AG  ONON.N : Baird initiates coverage with outperform rating and $38 PT
     * Papa John's International Inc  PZZA.O : Keybanc raises target price to $140 from $132
     * Parker-Hannifin Corp  PH.N : Melius Research raises to buy from hold
     * Passage Bio Inc  PASG.O : JP Morgan cuts target price to $22 from $32
     * Protagonist Therapeutics Inc  PTGX.O : Jefferies raises target price to $60 from $29
     * Protagonist Therapeutics Inc  PTGX.O : JP Morgan raises to overweight from neutral
     * Protagonist Therapeutics Inc  PTGX.O : JP Morgan raises target price to $55 from $49
     * Protagonist Therapeutics Inc  PTGX.O : SVB Leerink raises target price to $50 from $35
     * Reinsurance Group of America Inc  RGA.N : KBW raises to outperform from marketperform
     * Reinsurance Group of America Inc  RGA.N : KBW raises target price to $142 from $138
     * Sarepta Therapeutics Inc  SRPT.O : BTIG raises target price to $125 from $110
     * Sarepta Therapeutics Inc  SRPT.O : Credit Suisse raises target price to $100 from $75
     * Schlumberger NV  SLB.N : Piper Sandler raises target price to $32 from $31
     * Supernus Pharmaceuticals Inc  SUPN.O : Piper Sandler raises target price to $38 from $35
     * Targa Resources Corp  TRGP.N : JP Morgan raises target price to $66 from $59
     * TechnipFMC Plc  FTI.N : Piper Sandler raises target price to $9.6 from $9.25
     * Tenaris  TS.N : Piper Sandler raises target price to $29 from $28.5
     * Thoughtworks Holding Inc  TWKS.O : Baird initiates coverage with neutral rating; $31 PT
     * Tyra Biosciences Inc  TYRA.O : Jefferies initiates at buy with target price $19
     * Ulta Beauty Inc  ULTA.O : JP Morgan raises target price to $430 from $425
     * Weatherford International Plc  WFRD.O : Piper Sandler raises target price to $29 from $27
      

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on ForgeRock

See all news